Shanu Modi

机构：Memorial Sloan Kettering Cancer Center, Cornell University · ORCID：0000-0001-6427-7373

发表论文 425 篇 · 总被引 20559 次 · h-index 62

代表论文

Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial (2025 · Annals of Oncology · 被引 83)
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial (2025 · Nature Medicine · 被引 39)
Trastuzumab Deruxtecan Resistance via Loss of HER2 Expression and Binding (2025 · Cancer Discovery · 被引 37)
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study (2024 · Breast Cancer · 被引 29)
Phosphorylation-driven epichaperome assembly is a regulator of cellular adaptability and proliferation (2024 · Nature Communications · 被引 28)
Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis (2025 · Annals of Oncology · 被引 19)